AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02708550 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Participatory Organizational Intervention
Study NCT02185417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Description: Trial activities following study randomization were considered as usual care. Prescriptions of the allocated drug were managed by the primary care providers and patients would receive the prescribed mediations through the VA outpatient pharmacy services.
Study NCT02185417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorthalidone (CTD)
Description: Trial activities following study randomization were considered as usual care. Prescriptions of the allocated drug were managed by the primary care providers and patients would receive the prescribed mediations through the VA outpatient pharmacy services.
Study NCT01158560 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: cholecalciferol (vitamin D3)
Description: oral capsule, 10,000 IU/week vitamin D3 for 6-8 weeks
Study NCT01158560 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Gargling
Description: gargling with tap water, twice daily
Study NCT01158560 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gargling
Description: gargling with tap water, twice daily
Study NCT01158560 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matched placebo for active vitamin D
Study NCT01005069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS-32
Description: DLBS-32 50 mg once daily and lifestyle modification
Study NCT04043429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vision Restoration Training (VRT)
Study NCT04043429 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Vision Exploration Training (VET)
Study NCT02068911 — intervention group
Intervention type: DEVICE
Intervention: Monitoring of ETCO2 and PTCO2
Description: Concomitant monitoring of ETCO2 and PTCO2
Study NCT02044757 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SSB withdrawal
Description: During days 1-5, participants will drink the beverages they normally consume (no intervention). On days 6-8, participants will be instructed to drink only water and unflavored milk during the withdrawal period (days 6-8).
Study NCT03327389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: dexmedetomidine was infused at a rate of 0.4 μg/kg/h starting immediately after anesthetic induction and continued until skin closure.
Study NCT03327389 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 0.9% NaCl was infused at a rate of 0.4 μg/kg/h starting immediately after anesthetic induction and continued until skin closure
Study NCT00660296 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Air insufflation use in colonoscopy
Description: Air insufflation for colonic distension
Study NCT00660296 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CO2 use in colonoscopy
Description: Co2 insufflation for colonic distension
Study NCT02862145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRX34
Description: Treatment of melanoma with pharmacodynamics biopsy of tissue and blood
Study NCT02862145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Premedication during the week of treatment
Study NCT03137277 — intervention group
Intervention type: PROCEDURE
Intervention: screening colonoscopy
Description: Introduction and forwarding of the device up to caecum/terminal ileum. Then withdrawal and inspection of colonic wall. Biopsies and polypectomies if necessary. overall and diagnostic (only withdrawal) times being recorded separately.~Polyps are documented with regards to location (caecum, ascending, transverse and descending colon, sigmoid and rectum), size (open forceps or snare for comparison) and morphology using the Paris classification (polypoid pedunculated or sessile, non-polypoid slightly elevated/flat/depressed, ulcerous) Polyps were then resected using biopsy forceps or cold snare (for polyps \< 5 mm), or conventional polypectomy according to local standards.
Study NCT01753713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dovitinib
Description: Given PO
Study NCT01753713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT02543047 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Angioshield
Description: Angioshield is applied to vein graft to provide Mechanical Support for Vein Grafts Used in CABG Surgery
Study NCT04215562 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: rehabilitation
Description: electro-therapy, heat therapy, massage and exercise therapy
Study NCT02048124 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 25g standard needle
Study NCT02048124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 25d ProCor needle
Study NCT03984344 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation
Description: The Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer active TBS.
Study NCT03984344 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation
Description: The Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer active TBS.
Study NCT03984344 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Theta Burst Stimulation
Description: The Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer TBS using a sham Magstim coil.
Study NCT03810157 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching system
Description: The ZP was thinned or drilled with the Laser-assisted hatching system. The laser pulse was 0.296 ms. Laser aperture was 8μm.
Study NCT01468454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18 F-DOPA
Description: 1 time injection of 0.08 - 0.16 mCi/kg of 18F-DOPA
Study NCT02438280 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AcceleDent, Vibrational Device
Description: 20 minutes of vibration each day
Study NCT02438280 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AcceleDent, Vibrational Device
Description: 20 minutes of vibration each day
Study NCT02620787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tedizolid
Study NCT02620787 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tedizolid
Study NCT02620787 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microdialysis Catheter Insertion
Description: A 20 kila-Dalton microdialysis probe (63 MD catheter; MDialysis Inc., N. Chelmsford, MA) will be inserted into the subcutaneous tissue at the margin of the wound (patient group) or in the thigh tissue (healthy volunteers). The probe will be left in place for the final dose and all tissue sampling procedures thereafter. This probe is perfused with a physiologic solution to collect interstitial fluid samples. The probe will then be removed after completion of sample collection.
Study NCT02620787 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microdialysis Catheter Insertion
Description: A 20 kila-Dalton microdialysis probe (63 MD catheter; MDialysis Inc., N. Chelmsford, MA) will be inserted into the subcutaneous tissue at the margin of the wound (patient group) or in the thigh tissue (healthy volunteers). The probe will be left in place for the final dose and all tissue sampling procedures thereafter. This probe is perfused with a physiologic solution to collect interstitial fluid samples. The probe will then be removed after completion of sample collection.
Study NCT01005069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS-32
Description: DLBS-32 100 mg once daily and lifestyle modification
Study NCT01005069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS-32
Description: DLBS-32 200 mg once daily and lifestyle modification
Study NCT01005069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS-32
Description: DLBS-32 300 mg once daily and lifestyle modification
Study NCT01005069 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo capsules once daily and lifestyle modification
Study NCT04213391 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: sulforaphane
Description: Sulforaphane take 2550mg once a day.
Study NCT04213391 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo take 2550mg once a day.
Study NCT00710255 — intervention group
Intervention type: PROCEDURE
Intervention: Hyperpnea challenge
Description: 5 minutes of dry air hyperpnea to induce bronchospasm
Study NCT05459909 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Description: Daily supplementation of synbiotic
Study NCT05459909 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Increased fruits and vegetables consumption
Study NCT03353324 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravitreal injection of bevacizumab
Description: under gone 3 intravitreal injection of bevacizumab monthly and examine monthly for Visual acuity and central macular thickness, if in month four or more the CMT is more than 250 micrometer and the visual acuity is less than 8/10 the injection is repeatet and follow up in this manner is continued until 9 months.
Study NCT03353324 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: intravitreal injection of bevacizumab+ targeted laser
Description: patients in this group undergone laser photocoagulation of retinal non perfused areas based on FAG wide field imaging .~After 9 month follow up the outcomes such as Vusal acuity, Central macular thickness, intraocular pressure, neovascular formation are compared
Study NCT00875563 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zenith(R) Fenestrated AAA Endovascular Graft
Description: The Zenith(R) Fenestrated AAA Endovascular Graft with the H\&L-B One-Shot™ Introduction System is indicated for the endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms having morphology suitable for endovascular repair
Study NCT02104427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TG-0054 combined with G-CSF
Study NCT05826210 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopic sleeve gastrectomy
Description: Laparoscopic sleeve gastrectomy was performed in all patients with or without SO.
Study NCT01102712 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTVA System
Description: Unilateral Bronchoscopic Thermal Vapor Ablation for Lung Volume Reduction
Study NCT02277327 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plans of Action and Care Transitions
Description: Subjects randomized to the intervention will participate in action planning and care transitions (if hospitalized during the study period)
Study NCT02277327 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Routine Care
Description: Subjects randomized to the control group will continue to receive routine care within the medical home program
Study NCT03722082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhancing Cognitive Reserve
Description: The intervention is aimed at improving cognitive reserve in offsprings of patients diagnosed with schizophrenia or bipolar disorder. The program is composed of 12 sessions of 60 minutes and will be adapted according the three different age groups (6-12) (13-18) (18-25). Each group will include between 6-to-8 offsprings and conducted by 4 experienced neuropsychologists in both children and adults. The sessions are the following:
Study NCT03722082 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Support intervention
Description: The support group will schedule meetings with the participants in order to talk about their daily life with the possibility to talk about the difficulties they encounter.
Study NCT01841970 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: HET Bipolar System
Description: The HET Bipolar System is used to treat hemorrhoids by bipolar ligation of the superior hemorrhoidal blood supply.
Study NCT01425736 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Chemotherapy
Description: Chemotherapy :Docetaxel(75mg/m²,1 time/21d, 6times);Cisplatin(75mg/m²,1 time/21d, 6 times);Fluorouracil(750mg/m²/d,5times/21d, 30times)
Study NCT01425736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab and Chemotherapy
Description: Nimotuzumab treatment:(200mg/w,18weeks );~Chemotherapy treatment:(Docetaxel(75mg/m²,1 time/21d, 6times);Cisplatin(75mg/m²,1 time/21d, 6 times);Fluorouracil(750mg/m²/d,5times/21d, 30times)Nimotuzumab treatment:(200mg/w,18weeks );
Study NCT03861780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Project X 26ml
Description: Application of antiseptic drug to the inguinal and abdomen areas of the subjects
Study NCT03861780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Project X 5.1ml
Description: Application of antiseptic drug to the inguinal and abdomen areas of the subjects
Study NCT03861780 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prevantics Maxi Swabstick
Description: Application of antiseptic drug to the inguinal and abdomen areas of the subjects
Study NCT03278496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recovery Housing plus Counseling
Description: Participants receive 3 months of abstinence-contingent program-supported rent payment in community recovery housing. They also receive intensive outpatient counseling (both individual and group) focused on relapse prevention skills training, goal setting, employment seeking and recreational activities.
Study NCT03278496 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care Referral
Description: Participants are referred to an outpatient program of their choosing with an appointment made for them.
Study NCT03278496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recovery Housing Only
Description: Participant may receive up to 3 months of abstinence-contingent rent payment in community recovery housing but is not invited to participate in intensive counseling.
Study NCT00652912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clonazepam
Description: ODT, 1 mg
Study NCT00652912 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Klonopin Wafers
Description: ODT, 1 mg
Study NCT02182401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 207127 NA
Description: Days 3-8 and days 25-30
Study NCT02182401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 NA
Description: Days 15-30
Study NCT02182401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Days 1, 7, 23 and 29
Study NCT02182401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolbutamide
Description: Days 1, 7, 23 and 29
Study NCT02475434 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cream Supplement group
Description: Infants in the intervention arm will receive the cream supplement in addition to the standard regimen.
Study NCT04302402 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifaximin
Description: Rifaximin has been demonstrated in multiple IBS studies, through a postulated effect on the gut microbiota, to improve the symptoms of pain and bloating, which are important symptoms in subjects with functional dyspepsia
Study NCT04302402 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Similar looking placebo
Study NCT02219685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LDV/SOF
Description: 90/400 mg FDC tablet administered orally once daily
Study NCT02219685 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet administered orally once daily
Study NCT04789525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic training with high protein diet
Description: High-intensity aerobic training was given with 50 to 70 % of the maximum heart rate. the intervention started with 10 mins of warm-up exercise through stretching of upper and lower limb muscles. Subsequent to stretching, the subjects were asked to do 30 mins of exercises; consisting of 20 mins on the treadmill and 10 mins of cycle ergometer at 50 to 70 % of MHR, then with 10 mins of cool down.
Study NCT01848106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegnivacogin/anivamersen
Study NCT01848106 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bivalirudin
Study NCT00821275 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interventional radiological or surgical management
Description: Uterine artery embolization will be done for the patients who enroll into UAE group and desire for future pregancy and reserving uterus.Myomectomy will be performed for the patients who enroll into SURGERY group and desire for future pregancy and reserving uterus.Hysterectomy will be done for the patients who enroll into SURGERY group and don't desire for reserving uterus and/or future pregnancy.
Study NCT01854749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S1 combined with cisplatin
Study NCT03618446 — intervention group
Intervention type: OTHER
Intervention: The presence of a pelvic fracture
Study NCT02130947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Study NCT03225170 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Affirmation (SA)
Description: Clients will be asked to rank artistic skills, athletics, business/money, creativity, independence, music, politics, relationships with friends and family, religious values, sense of humor, spontaneity from most important to least important. They will then be asked to write about the item that is most important to them and why it may be important to them.
Study NCT03225170 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control
Description: Clients will be asked to rank artistic skills, athletics, business/money, creativity, independence, music, politics, relationships with friends and family, religious values, sense of humor, spontaneity from most important to least important. The control group will rank the list and be asked to write about the 9th ranked item and why it might be important to someone else.
Study NCT00480571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-1020
Description: BL-1020 Low Dose
Study NCT00480571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL 1020 High Dose
Description: BL 1020 High Dose
Study NCT02564276 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Study NCT01610037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QVA149
Description: QVA149 110/50 µg will be supplied as capsules in blister packs for once daily inhalation using the Novartis Concept1 SDDPI
Study NCT01610037 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tiotropium
Description: Tiotropium 18 µg will be supplied as capsules in blister packs for once daily inhalation using the HandiHaler SDDPI
Study NCT01610037 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo to QVA149A and Tiotropium will be supplied in the appropriate capsule in blister packs for use in either the Novartis Concept1 SDDPI or the HandiHaler SDDPI
Study NCT01048541 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Catheter - SpeediCath Compact Male
Description: Compact catheter for intermittent catheterisation
Study NCT01048541 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SpeediCath
Description: Catheter for intermittent catheterisation
Study NCT03641261 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic patient education program
Description: WebIchtyose is a specific therapeutic patient education program for patients with hereditary Ichthyosis targeting the problems of each patient by means of a personalized follow-up and a constant interaction between the patient and the educational team
Study NCT00627497 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Level Posterior Decompression
Description: The single level posterior decompression is a posterior surgical procedure.
Study NCT00627497 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DIAM Spinal Stabilization
Description: The DIAM Spinal Stabilization System is a spacer that is implanted between adjoining spinous processes using a posterior surgical approach.
Study NCT00627497 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DIAM Spinal Stabilization
Description: The DIAM Spinal Stabilization System is a spacer that is implanted between adjoining spinous processes using a posterior surgical approach
Study NCT00627497 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fusion
Description: Posterolateral Interbody Fusion
Study NCT03522116 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT00379145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trabectedin
Study NCT00980824 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Description: Six sessions brief CBT.